Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
35.12
+2.18 (6.62%)
At close: Feb 6, 2026, 4:00 PM EST
35.00
-0.12 (-0.34%)
After-hours: Feb 6, 2026, 6:23 PM EST

Spyre Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-148.97-208.02-338.79-83.82-65.8-80.89
Depreciation & Amortization
--0.961.9621
Loss (Gain) From Sale of Assets
-10--15.53---
Asset Writedown & Restructuring Costs
--132.77---
Loss (Gain) From Sale of Investments
-8.42-11.4-2.32-0.330.550.07
Stock-Based Compensation
37.0244.8325.687.118.046.26
Other Operating Activities
-38.6321.71102.530.43-0.340.33
Change in Accounts Receivable
--0.380.44-0.82-
Change in Accounts Payable
4.82-16.21-2.18-2.641.07-0.54
Change in Unearned Revenue
--0.58-0.883.58-
Change in Other Net Operating Assets
2.3111.68-3.97-2.42-1.99-2
Operating Cash Flow
-161.87-157.41-99.91-80.14-53.72-75.78
Capital Expenditures
----0.04-0.57-4.28
Sale of Property, Plant & Equipment
7-0.48---
Cash Acquisitions
--3.04---
Sale (Purchase) of Intangibles
--15---
Investment in Securities
-73.61-353.29-126.957.05-22.05-3.32
Investing Cash Flow
-66.61-353.29-108.3957.01-22.62-7.6
Long-Term Debt Repaid
---0.02-0.42-0.51-0.02
Net Debt Issued (Repaid)
---0.02-0.42-0.51-0.02
Issuance of Common Stock
227.49243.8984.9643.11.9154.53
Other Financing Activities
-5.67-1.84-5.79---
Financing Cash Flow
221.81410.91361.0842.681.39154.51
Foreign Exchange Rate Adjustments
-0.02-00.03-0.11-0.020.05
Net Cash Flow
-6.68-99.79152.819.44-74.9671.18
Free Cash Flow
-161.87-157.41-99.91-80.18-54.29-80.06
Free Cash Flow Margin
---11276.52%-3442.76%-289.71%-
Free Cash Flow Per Share
-2.74-3.35-14.49-23.78-20.64-37.50
Levered Free Cash Flow
-125.58-66.57-9.61-50.01-30.62-50.8
Unlevered Free Cash Flow
-125.58-66.57-9.61-50.01-30.62-50.8
Change in Working Capital
7.13-4.53-5.21-5.51.83-2.54
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q